Fig. 6
From: INAVA promotes aggressiveness of papillary thyroid cancer by upregulating MMP9 expression
INAVA positively correlates with FGF1 and MMP9 in PTC clinical specimens. a The expression of INAVA is associated with FGF1 and MMP9 in clinical PTC specimens. Two representative cases are shown. b Percentage of cases showing low (n = 57) or high (n = 55) INAVA expression in relation to the FGF1 and MMP9 expression levels. c The association between INAVA and FGF1 as well as MMP9 in 496 cases of PTC specimens using RNAseq data deposited on TCGA. The expression level of INAVA was divided into low (n = 248) and high (n = 248) groups according to median distribution. For b, c, *P < 0.05